*refer to PI-010 "Procedure for handling rapid alerts and recalls arising from quality defects" of the Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Upon receipt of the notification, the Department Market Monitoring of Medicines will contact you at the e-mail address provided under point 1.6. If any documents or attachments are available, please submit them spontaneously and directly to market.surveillance@swissmedic.ch; the same email address is also available for any questions relating to the notification.